BlackRock’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,352
| Closed | -$1.25K | – | 5568 |
|
|
2025
Q1 | $1.25K | Sell |
2,352
-2
| -0.1% | -$1 | ﹤0.01% | 5281 |
|
|
2024
Q4 | $12.4K | Hold |
2,354
| – | – | ﹤0.01% | 5104 |
|
|
2024
Q3 | $33.7K | Hold |
2,354
| – | – | ﹤0.01% | 4829 |
|
|
2024
Q2 | $38.1K | Hold |
2,354
| – | – | ﹤0.01% | 4861 |
|
|
2024
Q1 | $238K | Sell |
2,354
-859
| -27% | -$86.9K | ﹤0.01% | 4487 |
|
|
2023
Q4 | $75.8K | Hold |
3,213
| – | – | ﹤0.01% | 4809 |
|
|
2023
Q3 | $64.9K | Sell |
3,213
-84
| -3% | -$1.7K | ﹤0.01% | 4885 |
|
|
2023
Q2 | $85.7K | Sell |
3,297
-2,446
| -43% | -$63.6K | ﹤0.01% | 4877 |
|
|
2023
Q1 | $119K | Sell |
5,743
-1,209
| -17% | -$25.1K | ﹤0.01% | 4832 |
|
|
2022
Q4 | $142K | Buy |
6,952
+13
| +0.2% | +$265 | ﹤0.01% | 4862 |
|
|
2022
Q3 | $191K | Sell |
6,939
-180
| -3% | -$4.96K | ﹤0.01% | 4902 |
|
|
2022
Q2 | $188K | Sell |
7,119
-31,431
| -82% | -$830K | ﹤0.01% | 4958 |
|
|
2022
Q1 | $3.08M | Sell |
38,550
-64
| -0.2% | -$5.12K | ﹤0.01% | 4128 |
|
|
2021
Q4 | $7.87M | Buy |
38,614
+2,209
| +6% | +$450K | ﹤0.01% | 3736 |
|
|
2021
Q3 | $11.8M | Buy |
36,405
+20,093
| +123% | +$6.5M | ﹤0.01% | 3552 |
|
|
2021
Q2 | $4.24M | Buy |
16,312
+11,774
| +259% | +$3.06M | ﹤0.01% | 3879 |
|
|
2021
Q1 | $1.75M | Buy |
+4,538
| New | +$1.75M | ﹤0.01% | 4262 |
|